Question 1

Am I eligible for this trial based on my current treatment and health status?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Radiotherapy & Combi in Metastatic Melanoma clinical trial (NCT02392871). Contact the study team or your healthcare provider for specific answers.

Question 2

How does this combination treatment compare to other options I might have?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Radiotherapy & Combi in Metastatic Melanoma clinical trial (NCT02392871). Contact the study team or your healthcare provider for specific answers.

Question 3

What are the potential side effects of dabrafenib, trametinib, and radiotherapy?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Radiotherapy & Combi in Metastatic Melanoma clinical trial (NCT02392871). Contact the study team or your healthcare provider for specific answers.

Question 4

How often would I need to come in for treatment and check-ups?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Radiotherapy & Combi in Metastatic Melanoma clinical trial (NCT02392871). Contact the study team or your healthcare provider for specific answers.

Question 5

What should I expect during the treatment process?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Radiotherapy & Combi in Metastatic Melanoma clinical trial (NCT02392871). Contact the study team or your healthcare provider for specific answers.

Question 6

Are there any additional tests or monitoring I would need to undergo?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Radiotherapy & Combi in Metastatic Melanoma clinical trial (NCT02392871). Contact the study team or your healthcare provider for specific answers.

What this study is about